Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Mechanism Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dysbiosis | Preclinical | CN | 20 Dec 2022 | |
Nonalcoholic Steatohepatitis | Discovery | CN | 30 Nov 2022 |